SARS-CoV-2 感染对血液恶性瘤患者的影响:一项回顾性研究
Huihan Zhao1,2, Yu He3,4, Zhongqing Li1
1Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
Hematology (Amsterdam, Netherlands)
|December 8, 2023
概括
患有活跃血液性恶性瘤的患者面临来自SARS-CoV-2感染的更高风险. 康复后早期启动化疗是安全的,并建议,避免不必要的延迟.
科学领域:
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
- 在瘤学瘤学.
背景情况:
- 血液性恶性瘤 (HM) 可以损害免疫功能,增加对严重感染的易感性.
- SARS-CoV-2感染对HM患者的影响需要详细描述以指导临床管理.
研究的目的:
- 评估HM和SARS-CoV-2感染患者的临床特征.
- 确定与SARS-CoV-2严重程度和死亡率相关的风险因素.
主要方法:
- 74名HM和SARS-CoV-2感染的住院患者的回顾性分析 (2022年12月 - 2023年2月).
- 数据提取包括人口统计,病史,并发病,诊断,治疗和结果.
- 使用多变量分析来确定严重程度和死亡率的独立风险因素.
主要成果:
- 14.9%的患者经历了严重/危急的SARS-CoV-2感染,总体病例死亡率为10.8%.
- 急性髓性白血病 (AML) 和活跃的原发性血液病是严重的SARS-CoV-2感染的独立风险因素.
- 与其他HM类型相比,AML患者的不生存风险明显更高.
结论:
- 活跃的血液病是SARS-CoV-2感染患者不良结果的关键风险因素.
- 在SARS-CoV-2检测结果呈阴性后14天延迟开始化疗,目前的数据不支持,可能不必要.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
Immunodeficiency Diseases
947
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
947
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K


